A LIFESTYLE EPIDEMIC: OCULAR SURFACE DISEASE

2023-04-18
TFOS Report on Vision-Compromising Challenges Announced
BOSTON, April 18, 2023 /PRNewswire/ --
Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their new global
Workshop report, entitled "
A Lifestyle Epidemic: Ocular Surface Disease," which will be published this quarter in
The Ocular Surface journal.
The
World Health Organization indicates that eye problems are increasingly linked to lifestyle choices.1 "Lifestyle defines the way in which a person lives. The way we live can impact our environment, but it can also affect our health," explained
Dr. Jennifer Craig, Professor, Department of Ophthalmology and Head of the Ocular Surface Laboratory at the University of Auckland in New Zealand.
"This new TFOS Report focuses on the direct and indirect impacts that everyday lifestyle choices and challenges have on ocular surface health – from screen time, to our beauty routines, to our nutrition, to where we live," stated
Amy Gallant Sullivan, Executive Director, TFOS. "It is our mission as a world-renowned scientific society to advance our understanding and educate the public and professionals about how our choices impact our eyes, our vision, and our quality of life," commented
Dr. Monica Alves, Professor, Department of Ophthalmology, University of Campinas, Brazil.
"The study of ocular surface disease has evolved dramatically in the last years and TFOS has played an instrumental role in this transformation," explained
Dr. Jennifer Craig "TFOS Reports play a critical role in consolidating and translating published science and literature while inspiring future research by identifying the gaps and unmet needs."
"This TFOS Lifestyle Workshop report involved 158 experts from 38 countries around the world, required almost three years to complete, and was committed to an evidence-based approach and a process of open communication, dialogue and transparency, in order to achieve a consensus concerning lifestyle choices and ocular surface disease," concluded
David A. Sullivan, PhD, Founder, TFOS.
ABOUT TFOS
Founded in 2000, the Tear Film & Ocular Surface Society is a world leader in eye health education headquartered in Boston, USA. A 501(c)3 non-profit foundation, TFOS is dedicated to advancing the research, literacy, and educational aspects of the scientific field of the eye's surface. More information about TFOS and the Report is available at: https://www.tearfilm.org/.
Note to Editors: The TFOS Lifestyle Workshop was supported by unrestricted donations to TFOS from Alcon, Allergan an AbbVie Company, Bausch + Lomb, Bruder Healthcare, CooperVision, CSL Seqirus, Dompé, ESSIRI Labs, ESW-Vision, Eye Drop Shop, I-MED Pharma, KALA Pharmaceuticals, Laboratoires Théa, Santen, Novartis, Shenyang Sinqi Pharmaceutical, Sun Pharmaceutical Industries, Tarsus Pharmaceuticals, Trukera Medical and URSAPHARM.
1. World report on vision (2019) Retrieved from https://www-who-int.libproxy1.nus.edu.sg/publications/i/item/world-report-on-vision
Tear Film & Ocular Surface Society
Boston, MA - 02113 USA
Amy Gallant Sullivan
Executive Director
+1617-605-7128
[email protected] @Eyeppl
SOURCE TFOS - Tear Film & Ocular Surface Society
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。